Tourmaline Bio, Inc. financial data

Symbol
TRML on Nasdaq
Location
27 West 24 Th Street, Suite 702, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.16K % -20%
Debt-to-equity 2.94 % 0%
Return On Equity -30.5 % -31.5%
Return On Assets -29.6 % -60.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.7M shares +0.2%
Common Stock, Shares, Outstanding 25.7M shares +0.17%
Entity Public Float 294M USD +227%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 25.8M shares +0.12%
Weighted Average Number of Shares Outstanding, Diluted 25.8M shares +0.12%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 79.8M USD +105%
General and Administrative Expense 22.7M USD +2.48%
Operating Income (Loss) -102M USD -67.9%
Net Income (Loss) Attributable to Parent -88.5M USD -79.5%
Earnings Per Share, Basic -3 USD/shares -124%
Earnings Per Share, Diluted -3 USD/shares -124%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 31.4M USD -55.2%
Marketable Securities, Current 79.9M USD -54.4%
Cash, Cash Equivalents, and Short-term Investments 232M USD +0.58%
Other Assets, Current 1.49M USD +92.3%
Assets, Current 249M USD -16.4%
Property, Plant and Equipment, Net 47K USD -27.7%
Operating Lease, Right-of-Use Asset 127K USD -56.2%
Intangible Assets, Net (Excluding Goodwill) 0 USD
Goodwill 0 USD
Other Assets, Noncurrent 2.61M USD +117%
Assets 269M USD -21.9%
Accounts Payable, Current 3.17M USD +32.8%
Accrued Liabilities, Current 6.78M USD +80.8%
Liabilities, Current 10.1M USD +58.7%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 8K USD -79.5%
Liabilities 10.1M USD +55.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 121K USD
Retained Earnings (Accumulated Deficit) -181M USD -95.3%
Stockholders' Equity Attributable to Parent 259M USD -23.4%
Liabilities and Equity 269M USD -21.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -21.7M USD -45.3%
Net Cash Provided by (Used in) Financing Activities 562K USD -99.7%
Net Cash Provided by (Used in) Investing Activities 25.9M USD
Common Stock, Shares Authorized 140M shares 0%
Common Stock, Shares, Issued 25.7M shares +0.17%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.82M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 31.7M USD -55%
Deferred Tax Assets, Valuation Allowance 46.4M USD +36.2%
Deferred Tax Assets, Gross 49.5M USD +37.9%
Operating Lease, Liability 244K USD -41.2%
Depreciation 12K USD +20%
Payments to Acquire Property, Plant, and Equipment 9K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -87.9M USD -76.7%
Lessee, Operating Lease, Liability, to be Paid 265K USD -45.5%
Property, Plant and Equipment, Gross 132K USD +7.32%
Operating Lease, Liability, Current 145K USD -35.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 38K USD -83.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 227K USD +2.72%
Operating Lease, Weighted Average Discount Rate, Percent 0.16 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21K USD -70.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 11.2M USD +105%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 200K USD -77.8%
Additional Paid in Capital 440M USD +2.04%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 436K USD +46.8%
Deferred Tax Assets, Net of Valuation Allowance 3.1M USD +68%
Share-based Payment Arrangement, Expense 8.16M USD +0.22%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%